A detailed history of Siemens Fonds Invest Gmb H transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Siemens Fonds Invest Gmb H holds 69,501 shares of BMY stock, worth $4.09 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
69,501
Previous 69,501 -0.0%
Holding current value
$4.09 Million
Previous $2.89 Million 24.6%
% of portfolio
0.26%
Previous 0.22%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $27,209 - $35,821
676 Added 0.98%
69,501 $2.89 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $148,258 - $168,096
-3,090 Reduced 4.3%
68,825 $3.73 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $662,721 - $790,809
13,670 Added 23.47%
71,915 $3.69 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $46,080 - $51,525
796 Added 1.39%
58,245 $3.38 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $17,347 - $19,675
-264 Reduced 0.46%
57,449 $3.98 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $234,749 - $277,976
-3,428 Reduced 5.61%
57,713 $4.15 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $231 - $136,544
-1,777 Reduced 2.82%
61,141 $4.35 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $81,915 - $90,217
-1,128 Reduced 1.76%
62,918 $4.85 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $32,584 - $39,071
-530 Reduced 0.82%
64,046 $4.68 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $82,482 - $96,155
1,538 Added 2.44%
64,576 $4.04 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $158,220 - $185,334
2,674 Added 4.43%
63,038 $3.73 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $6.03 Million - $6.57 Million
-97,457 Reduced 61.75%
60,364 $4.03 Million
Q1 2021

Jul 14, 2021

SELL
$59.34 - $66.74 $761,569 - $856,541
-12,834 Reduced 7.52%
157,821 $9.96 Million
Q4 2020

Jul 14, 2021

BUY
$57.74 - $65.43 $9.85 Million - $11.2 Million
170,655 New
170,655 $10.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Siemens Fonds Invest Gmb H Portfolio

Follow Siemens Fonds Invest Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siemens Fonds Invest Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Siemens Fonds Invest Gmb H with notifications on news.